GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 247 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $27,322,000 | +3315.2% | 401,197 | +2665.2% | 0.06% | +5500.0% |
| Q3 2020 | $800,000 | -39.3% | 14,509 | -30.6% | 0.00% | -50.0% |
| Q2 2020 | $1,319,000 | -11.6% | 20,904 | -28.4% | 0.00% | 0.0% |
| Q1 2020 | $1,492,000 | -28.9% | 29,199 | +10.6% | 0.00% | 0.0% |
| Q4 2019 | $2,098,000 | +409.2% | 26,389 | +211.0% | 0.00% | – |
| Q3 2019 | $412,000 | -73.0% | 8,484 | -70.7% | 0.00% | -100.0% |
| Q2 2019 | $1,525,000 | +193.3% | 29,000 | +195.4% | 0.00% | 0.0% |
| Q1 2019 | $520,000 | -66.5% | 9,817 | -74.3% | 0.00% | -50.0% |
| Q4 2018 | $1,553,000 | -4.0% | 38,129 | -10.4% | 0.00% | +100.0% |
| Q3 2018 | $1,617,000 | -24.2% | 42,542 | -9.8% | 0.00% | -50.0% |
| Q2 2018 | $2,132,000 | +14.3% | 47,183 | +22.2% | 0.00% | 0.0% |
| Q1 2018 | $1,865,000 | -1.9% | 38,605 | -20.1% | 0.00% | 0.0% |
| Q4 2017 | $1,902,000 | – | 48,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |